Myomatous erythrocytosis syndrome
Myomatous erythrocytosis syndrome is a rare medical condition characterized by the presence of uterine fibroids (myomas) and an associated increase in red blood cell mass, leading to erythrocytosis. This syndrome is notable for its unique combination of gynecological and hematological abnormalities.
Pathophysiology[edit | edit source]
The exact mechanism underlying myomatous erythrocytosis syndrome is not fully understood. However, it is believed that the uterine fibroids may produce erythropoietin, a hormone that stimulates the production of red blood cells in the bone marrow. This overproduction of erythropoietin leads to erythrocytosis, which is characterized by an elevated hematocrit and hemoglobin levels.
Clinical Presentation[edit | edit source]
Patients with myomatous erythrocytosis syndrome typically present with symptoms related to both the uterine fibroids and the increased red blood cell mass. Common symptoms include:
- Menorrhagia (heavy menstrual bleeding)
- Pelvic pain
- Abdominal distension
- Fatigue
- Headaches
- Dizziness
Diagnosis[edit | edit source]
The diagnosis of myomatous erythrocytosis syndrome involves a combination of clinical evaluation, laboratory tests, and imaging studies. Key diagnostic steps include:
- Complete blood count (CBC) to assess hemoglobin and hematocrit levels
- Measurement of serum erythropoietin levels
- Pelvic ultrasound or MRI to identify and evaluate uterine fibroids
- Exclusion of other causes of erythrocytosis, such as polycythemia vera and chronic hypoxia
Treatment[edit | edit source]
The treatment of myomatous erythrocytosis syndrome focuses on managing both the uterine fibroids and the erythrocytosis. Treatment options may include:
- Myomectomy or hysterectomy to remove the uterine fibroids
- Medications to reduce erythropoietin production or red blood cell mass
- Phlebotomy to decrease hematocrit levels
Prognosis[edit | edit source]
The prognosis for patients with myomatous erythrocytosis syndrome varies depending on the severity of the condition and the effectiveness of the treatment. Surgical removal of the uterine fibroids often leads to a resolution of the erythrocytosis and improvement in symptoms.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD